反応 #67021

ord-e6d0670da6dc407d95181f956bd66a2a

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他The solvent and the excess reagent were removed under reduced pressure
  2. 2
    workup.DISSOLUTIONThe solid residue was again dissolved in dichloromethane (5 ml) and, at 0° C.
  3. 3
    workup.STIRRINGThe reaction mixture was stirred at room temperature overnight
  4. 4
    その他the aqueous phase was removed
  5. 5
    抽出extracted with ethyl acetate
  6. 6
    乾燥The combined organic phases were dried over sodium sulphate
  7. 7
    濃縮concentrated
  8. 8
    その他Purification by column chromatography

実験手順

To a solution of [3,5-bis-(difluoromethyl)-1H-pyrazol-1-yl]acetic acid (58 mg) in dichloromethane (20 ml) were added, at 0° C., oxalyl chloride (94.5 mg) and one drop of N,N-dimethylformamide. The reaction mixture was stirred at room temperature for 2 hours. The solvent and the excess reagent were removed under reduced pressure. The solid residue was again dissolved in dichloromethane (5 ml) and, at 0° C., added dropwise to a solution of 4-{4-[5-(2-fluoro-6-formylphenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidinium chloride and triethylamine (5.0 eq.) in dichloromethane (15 ml). The reaction mixture was stirred at room temperature overnight. Then it was admixed with concentrated sodium hydrogencarbonate solution, and the aqueous phase was removed and extracted with ethyl acetate. The combined organic phases were dried over sodium sulphate and concentrated. Purification by column chromatography gave 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-fluorobenzaldehyde (55 mg).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US08524743B2uspto-grants-2013_09